This is an external website. ITN is not responsible for any content on the third party website.
Bracco to Open U.S. Contrast Media Manufacturing Facility
Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...
Blue Earth Diagnostics to Present New Research on Precision Molecular ...
Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...
Focused Ultrasound Foundation, Bracco Announce Microbubble Partnership ...
Aug. 13, 2026 — The Focused Ultrasound Foundation and Bracco Imaging have announced a partnership to facilitate access ...
Ultrasound Contrast Delivery System Receives FDA Clearance
Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...
Canadian Hospital Implements Low-Dose MRI Contrast Agent for ...
Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...
Bracco Recognized for Sustainability Efforts
July 20, 2026 — Bracco Imaging has earned the 2026 EcoVadis Platinum Medal, the highest level of recognition awarded by ...
Bracco to Install Photon-Counting CT Scanner at Research Center
May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...
Bracco, ACIST Medical Systems Receive FDA Clearance of ACIST Pro ...
May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...
Bracco, NYU Langone to Collaborate on Imaging Research
April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in ...
FDA Expands Approval of Low-Dose MRI Contrast Agent to Include ...
Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...